November 18, 2013 / 9:43 PM / 4 years ago

BRIEF-Intellipharmaceutics/ Par to commercially launch 15 and 30 mg generic Focalin XR

Nov 18 (Reuters) - Intellipharmaceutics International Inc : * / Par to make immediate commercial launch of 15 and 30 mg generic Focalin

XR(R) * FDA granted final approval of dexmethylphenidate hydrochloride

extended-release capsules for 15 and 30 mg strengths * Co’s dexmethylphenidate hydrochloride extended-release capsules 5, 10, 20 and

40 mg strengths were also tentatively FDA approved * Source text for Eikon * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below